Ownership and insider activity for Kenvue Inc. (KVUE): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec.
Price
| Price | $17.39 |
| Market Cap | $33.4B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-01 | Wondrasch Michael | M-Exempt | 66,028 | |
| 2026-10-01 | Wondrasch Michael | M-Exempt | 66,028 | |
| 2026-10-01 | Wondrasch Michael | F-InKind | 21,031 | $362K |
| 2026-09-28 | Smith Jeffrey C | A-Award | 1,300 | |
| 2026-09-25 | Stevens Meredith | M-Exempt | 1,032 | |
| 2026-09-25 | Stevens Meredith | M-Exempt | 429 | |
| 2026-09-25 | Stevens Meredith | M-Exempt | 1,032 | |
| 2026-09-25 | Stevens Meredith | F-InKind | 1,032 | $18K |
| 2026-09-25 | Stevens Meredith | M-Exempt | 429 | |
| 2026-09-28 | ALLISON RICHARD E JR | A-Award | 1,300 |
Balance Sheet (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $618.0M | $740.0M | $1.23B | $1.38B | $1.07B | $1.06B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $2.13B | $2.33B | $2.30B | $2.64B | $2.66B | $2.81B |
| Inventory | $1.69B | $1.70B | $2.23B | $1.85B | $1.59B | $1.67B |
| Total Current Assets | $4.59B | $4.93B | $5.88B | $6.14B | $5.53B | $5.70B |
| Property, Plant & Equipment | $1.96B | $1.83B | $1.82B | $2.04B | $1.85B | $2.21B |
| Goodwill | $10.33B | $9.81B | $9.19B | $9.27B | $8.84B | $9.51B |
| Intangible Assets | $11.61B | $10.70B | $9.85B | $9.62B | $8.47B | $8.69B |
| Total Assets | $29.18B | $27.93B | $27.32B | $27.85B | $25.60B | $27.08B |
| Accounts Payable | $1.58B | $1.83B | $1.83B | $2.49B | $2.25B | $2.47B |
| Short-term Debt | 0 | 0 | 0 | $599.0M | $1.55B | $1.45B |
| Total Current Liabilities | $7.49B | $4.04B | $3.93B | $5.48B | $5.74B | $5.95B |
| Long-term Debt | 0 | 0 | $8.93B | $7.69B | $6.94B | $7.07B |
| Total Liabilities | $10.82B | $7.53B | $7.35B | $16.64B | $15.93B | $16.31B |
| Retained Earnings | 0 | 0 | 0 | $429.0M | -$93.0M | -$204.0M |
| Total Equity | $18.36B | $20.40B | $19.97B | $11.21B | $9.67B | $10.77B |
| Total Debt | 0 | $129.0M | $9.05B | $8.43B | $8.72B | $8.52B |
| Net Debt | -$618.0M | -$611.0M | $7.82B | $7.04B | $7.65B | $7.46B |
| Working Capital | -$2.90B | $885.0M | $1.95B | $657.0M | -$214.0M | -$248.0M |
Financial Health
| Debt / Equity | 0.80 |
| Current Ratio | 1.01 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 2.08 |
Profitability
| Return on Equity | 13.66% |
| Return on Invested Capital | 8.80% |
| Return on Assets | 5.43% |
| Gross Margin | 58.19% |
| Operating Margin | 19.52% |
| Net Margin | 10.76% |
Related companies: ADM · CHD · EL · HSY · JBS · K · KDP
Explore sector: Consumer Defensive · Household & Personal Products
More sections of KVUE: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks